NASDAQ:NXGL NEXGEL (NXGL) Stock Price, News & Analysis → Central Bank Gold Heist In Progress (From Colonial Metals) (Ad) Free NXGL Stock Alerts $2.78 +0.19 (+7.34%) (As of 03/18/2024 ET) Add Compare Share Share Today's Range$2.47▼$2.8450-Day Range$1.97▼$2.9652-Week Range$1.25▼$3.14Volume79,293 shsAverage Volume33,129 shsMarket Capitalization$15.90 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Get NEXGEL alerts: Email Address Ad Crypto 101 MediaLike Tiny Crypto Retirement FundsThe crypto bull market is about to blast off. Bitcoin and Ethereum are surging. But so are tiny altcoins that could be so profitable… They're like tiny crypto retirement funds. Click here and see how to get a copy. About NEXGEL Stock (NASDAQ:NXGL)NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. The company was incorporated in 2009 and is based in Langhorne, Pennsylvania.Read More NXGL Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NXGL Stock News HeadlinesMarch 4, 2024 | globenewswire.comNEXGEL to Present at the iAccess Alpha Best Ideas Spring Virtual Conference on March 12thFebruary 24, 2024 | msn.comNEXGEL (NXGL) Price Target Increased by 16.67% to 7.14March 19, 2024 | Crypto Swap Profits (Ad)Claim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.February 23, 2024 | msn.comNEXGEL Raises Capital, Strengthens Balance Sheet Amid Growth OpportunitiesFebruary 21, 2024 | finance.yahoo.comNEXGEL Announces $975,000 Registered Direct Offering Led by InsidersJanuary 18, 2024 | finance.yahoo.comNEXGEL to Present at The Microcap Conference, January 30th through February 1stJanuary 9, 2024 | finance.yahoo.comNEXGEL Subsidiary, CG Converting and Packaging, Begins 12,000 Square Foot Expansion of Texas Facility to Support the Expected Growth in Product Demand in 2024December 11, 2023 | finance.yahoo.comNEXGEL Announces Partnership with STADA to Distribute and Commercialize Consumer Health OTC Products in North AmericaMarch 19, 2024 | InvestorPlace (Ad)They said crypto was dead. It went up 100X.Bitcoin’s haters are out again. Despite the price doubling in the last six months alone… That hasn’t stopped the experts from piling on. Warren Buffett’s right-hand man Charlie Munger called crypto investors “idiots” in one of his last interviews. JPMorgan CEO Jamie Dimon, recently called Bitcoin a “pet rock” and “a hyped-up fraud.” But when it comes to cryptos, these are exactly the people you shouldn’t listen to. They’ve predicted crypto’s demise for years.December 7, 2023 | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: Veeva Systems (VEEV), Neurocrine (NBIX)December 5, 2023 | finance.yahoo.comNEXGEL Acquires Kenkoderm Psoriasis Skincare LineNovember 27, 2023 | msn.comNexgel (NXGL) Price Target Increased by 20.00% to 6.12November 26, 2023 | finance.yahoo.comNEXGEL, Inc. (NASDAQ:NXGL): When Will It Breakeven?November 20, 2023 | insidermonkey.comNEXGEL, Inc. (NASDAQ:NXGL) Q3 2023 Earnings Call TranscriptNovember 13, 2023 | msn.comNEXGEL GAAP EPS of -$0.10 beats by $0.02, revenue of $1.2M in-lineNovember 13, 2023 | finance.yahoo.comNEXGEL Reports Record Third Quarter 2023 Revenue of $1.2 Million, an Increase of 115% Year-Over-YearNovember 3, 2023 | bizjournals.comLab Notes: Montco medical technology company taps familiar face as CEONovember 2, 2023 | finance.yahoo.comNEXGEL to Report Third Quarter 2023 Financial Results on November 13thOctober 30, 2023 | proactiveinvestors.comNEXGEL announces supply agreement with AbbVieOctober 30, 2023 | finance.yahoo.comNEXGEL Secures Supply Agreement with AbbVieSeptember 26, 2023 | proactiveinvestors.comNEXGEL CEO to present at LD Micro Main Event XVI in Los AngelesSeptember 26, 2023 | finance.yahoo.comNEXGEL to Participate in the LD Micro Main Event XVI on October 3rdSeptember 15, 2023 | finance.yahoo.comDirector Scott Henry Acquires 10,500 Shares of NexGel IncAugust 19, 2023 | finance.yahoo.comNEXGEL, Inc. (NASDAQ:NXGL) Q2 2023 Earnings Call TranscriptAugust 16, 2023 | markets.businessinsider.comMaxim Group Reaffirms Their Buy Rating on NexGel Inc (NXGL)August 14, 2023 | finance.yahoo.comNEXGEL Reports Second Quarter 2023 Record Revenue of $1.17 Million, an Increase of 108% Year-Over-YearAugust 2, 2023 | finance.yahoo.comNEXGEL to Report Second Quarter 2023 Financial Results on August 14thSee More Headlines Receive NXGL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NEXGEL and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/27/2023Today3/19/2024Next Earnings (Estimated)3/25/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:NXGL CUSIPN/A CIK1468929 Webnexgel.com Phone215-702-8550FaxN/AEmployees12Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.48) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-4,750,000.00 Net Margins-76.64% Pretax Margin-75.00% Return on Equity-38.69% Return on Assets-25.90% Debt Debt-to-Equity Ratio0.04 Current Ratio3.58 Quick Ratio2.92 Sales & Book Value Annual Sales$2.05 million Price / Sales7.76 Cash FlowN/A Price / Cash FlowN/A Book Value$1.37 per share Price / Book2.03Miscellaneous Outstanding Shares5,720,000Free Float4,166,000Market Cap$15.90 million OptionableNot Optionable Beta0.65 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Adam R. Levy (Age 61)CEO, President & Director Comp: $334.51kMr. Adam E. Drapczuk III (Age 48)Chief Financial Officer Comp: $131.04kMr. Gregory RobbVice President of OperationsKey CompetitorsT2 BiosystemsNASDAQ:TTOOPetVivoNASDAQ:PETVMicrobot MedicalNASDAQ:MBOTSTRATA Skin SciencesNASDAQ:SSKNMeihua International Medical TechnologiesNASDAQ:MHUAView All CompetitorsInsidersScott Robert HenryBought 23,697 shares on 3/1/2024Total: $50,000.67 ($2.11/share)Adam E Drapczuk IIIBought 47,394 shares on 3/1/2024Total: $100,001.34 ($2.11/share)Steven Mark GlassmanBought 3,885 shares on 12/22/2023Total: $8,547.00 ($2.20/share)John Nachum SteinBought 2,500 shares on 9/26/2023Total: $4,900.00 ($1.96/share)Scott Robert HenryBought 500 shares on 9/14/2023Total: $1,135.00 ($2.27/share)View All Insider Transactions NXGL Stock Analysis - Frequently Asked Questions How have NXGL shares performed in 2024? NEXGEL's stock was trading at $2.13 at the beginning of 2024. Since then, NXGL stock has increased by 30.5% and is now trading at $2.78. View the best growth stocks for 2024 here. Are investors shorting NEXGEL? NEXGEL saw a increase in short interest in February. As of February 29th, there was short interest totaling 15,400 shares, an increase of 208.0% from the February 14th total of 5,000 shares. Based on an average daily volume of 18,600 shares, the days-to-cover ratio is presently 0.8 days. Approximately 0.4% of the company's shares are short sold. View NEXGEL's Short Interest. When is NEXGEL's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, March 25th 2024. View our NXGL earnings forecast. How were NEXGEL's earnings last quarter? NEXGEL, Inc. (NASDAQ:NXGL) issued its quarterly earnings results on Monday, March, 27th. The company reported ($0.11) EPS for the quarter, topping the consensus estimate of ($0.15) by $0.04. The firm had revenue of $0.52 million for the quarter. NEXGEL had a negative trailing twelve-month return on equity of 38.69% and a negative net margin of 76.64%. When did NEXGEL IPO? (NXGL) raised $14 million in an initial public offering on Wednesday, December 22nd 2021. The company issued 2,100,000 shares at $6.83 per share. Maxim Group LLC acted as the underwriter for the IPO. How do I buy shares of NEXGEL? Shares of NXGL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:NXGL) was last updated on 3/19/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial Metals8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)Paradigm PressLike Tiny Crypto Retirement FundsCrypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceStock-Picking AI Predicts #1 Stock of 2024AltimetrySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyThe world’s greatest investmentPorter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NEXGEL, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.